Hospitals | December 01, 2021
Jaslok Hospital launches heart transplant programme in Mumbai
The country’s top heart transplant surgeon Dr. K.R Balakrishnan to be leading the programme for Jaslok
The country’s top heart transplant surgeon Dr. K.R Balakrishnan to be leading the programme for Jaslok
Dabigatran Etexilate capsules are indicated to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation, and for the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE)
Nelarabine is in a class of medications called antimetabolites
Six-months follow-up of prevention trial showed 83% reduced risk of symptomatic Covid-19, with no severe disease or deaths
The Indian Pharmacopoeia Commission (IPC) has added 23 new impurities standards and 7 new Indian Pharmacopoeial Reference standards
The group now has 324 approvals and has so far filed over 400 ANDAs
The interim data combines three mRNAs into one therapy injected directly into the tumour
The start-up has announced the scheme to mark World Diabetes Day
Ind-Ra continues to expect IPM’s revenue to grow over 12% yoy in FY22
Glycopyrrolate injection can also be used in adults as an adjunctive therapy for the treatment of gastrointestinal ulcer when a rapid effect is desired or when oral medication is not tolerated
Subscribe To Our Newsletter & Stay Updated
